Estriol — Class II drug recall D-0622-2020
Terminated recall by Medisca, Inc., reported 2019-12-25, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0622-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medisca, Inc., Plattsburgh, NY, United States |
| Recall initiated | 2019-11-25 |
| Classified | 2019-12-16 |
| Reported by FDA | 2019-12-25 |
| Terminated | 2021-03-17 |
| Distributed | Nationwide (US) |
| Quantity | 640,325 grams |
| Reason classes | specification failure |
| Lot numbers | 153328, 156110, 161726 |
Product
Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0622-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.